Harvard Bioscience Aktie
0,42
EUR
±0,00
EUR
+0,48
%
0,52
USD
+0,01
USD
+2,24
%
Werbung
Harvard Bioscience Aktie Analyse
23.01.18 | Harvard Bioscience Buy | The Benchmark Company | |
17.11.16 | Harvard Bioscience Buy | Singular Research | |
28.07.15 | Harvard Bioscience Buy | The Benchmark Company | |
20.07.06 | Harvard Bioscience outperform | Thomas Weisel Partners |
Werbung
Werbung